Elizabeth Homans

Elizabeth Homans

Chief Executive Officer at Immulus, Inc.

Net worth: - $ as of 30/03/2024

58 year
Health Technology
Consumer Services
Health Services

Profile

Elizabeth Homans is currently the Chief Executive Officer at Immulus, Inc. and also serves as the Director at Delfi Diagnostics, Inc. She was previously the Chief Executive Officer & Director at Lyell Immunopharma, Inc. and Executive Director-Project Leadership at Jazz Pharmaceuticals, Inc. Ms. Homans holds an MBA from The Trustees of Columbia University in The City of New York and an undergraduate degree from Bates College.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
30/03/2023 0 ( -.--% ) - $ 30/03/2024

Elizabeth Homans active positions

CompaniesPositionStart
Chief Executive Officer -
Director/Board Member 29/03/2022
All active positions of Elizabeth Homans

Former positions of Elizabeth Homans

CompaniesPositionEnd
LYELL IMMUNOPHARMA, INC. Chief Executive Officer 14/12/2022
Corporate Officer/Principal 31/10/2007
See the detail of Elizabeth Homans's experience

Training of Elizabeth Homans

The Trustees of Columbia University in The City of New York Masters Business Admin
Bates College Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Elizabeth Homans's experience

Connections

22

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
LYELL IMMUNOPHARMA, INC.

Health Technology

Private companies3

Health Technology

Health Services

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Elizabeth Homans